U.S. Physical Therapy, Inc. (NYSE:USPH)‘s stock had its “buy” rating reaffirmed by Cantor Fitzgerald in a report issued on Thursday. They currently have a $74.00 target price on the stock. Cantor Fitzgerald’s price objective points to a potential upside of 11.61% from the company’s previous close.

The analysts wrote, “Storm impact contained, outlook fine. Hurricanes cost an estimated $0.03 per share in 3Q17, fully diluted EPS were $0.48 (vs. our $0.52 estimate), and we are reducing our full year 2017 estimate to $2.10 (from $2.15). We are raising our 2018 estimate to $2.45 (from $2.40). Our corresponding full year adjusted EBITDA estimates (3Q17 results were about $900,000 shy of our $14.6 million estimate) are $57.7 million for 2017 (vs. prior $58.6 million) and $65.5 million (vs. prior $63.7 million ) for 2018. Commercial reimbursement rates look fine for 2018; the average reimbursement for commercial is $100 vs. Medicare’s $90.””

Other analysts also recently issued reports about the company. Sidoti upgraded U.S. Physical Therapy from a “neutral” rating to a “buy” rating and raised their target price for the company from $62.00 to $74.00 in a research note on Friday, September 8th. Zacks Investment Research upgraded U.S. Physical Therapy from a “hold” rating to a “buy” rating and set a $64.00 price target for the company in a research note on Tuesday, August 29th. Jefferies Group LLC set a $65.00 price target on U.S. Physical Therapy and gave the company a “hold” rating in a research note on Friday, August 4th. Finally, BidaskClub upgraded U.S. Physical Therapy from a “sell” rating to a “hold” rating in a research note on Wednesday, October 25th. One equities research analyst has rated the stock with a sell rating, four have given a hold rating and two have given a buy rating to the company’s stock. The company presently has an average rating of “Hold” and a consensus price target of $69.00.

Shares of U.S. Physical Therapy (USPH) traded down $1.75 on Thursday, hitting $66.30. The stock had a trading volume of 105,690 shares, compared to its average volume of 66,321. The company has a debt-to-equity ratio of 0.30, a quick ratio of 2.26 and a current ratio of 2.04. The company has a market capitalization of $906.48, a price-to-earnings ratio of 34.81, a P/E/G ratio of 2.99 and a beta of 1.07.

U.S. Physical Therapy (NYSE:USPH) last issued its earnings results on Thursday, November 2nd. The company reported $0.48 EPS for the quarter, missing the Thomson Reuters’ consensus estimate of $0.52 by ($0.04). The firm had revenue of $103.03 million during the quarter, compared to analyst estimates of $102.69 million. U.S. Physical Therapy had a net margin of 6.13% and a return on equity of 10.27%. research analysts forecast that U.S. Physical Therapy will post 2.14 EPS for the current year.

COPYRIGHT VIOLATION WARNING: This article was posted by Watch List News and is the property of of Watch List News. If you are reading this article on another publication, it was copied illegally and republished in violation of United States & international trademark & copyright law. The original version of this article can be viewed at https://www.watchlistnews.com/u-s-physical-therapy-inc-usph-stock-rating-reaffirmed-by-cantor-fitzgerald/1679065.html.

In other U.S. Physical Therapy news, CFO Lawrance W. Mcafee sold 3,000 shares of U.S. Physical Therapy stock in a transaction dated Friday, August 11th. The stock was sold at an average price of $62.04, for a total transaction of $186,120.00. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, COO Glenn Mcdowell sold 2,598 shares of U.S. Physical Therapy stock in a transaction that occurred on Wednesday, August 30th. The stock was sold at an average price of $57.00, for a total transaction of $148,086.00. The disclosure for this sale can be found here. Insiders have sold a total of 13,266 shares of company stock valued at $801,134 in the last quarter. Company insiders own 3.10% of the company’s stock.

Institutional investors have recently bought and sold shares of the business. Pinebridge Investments L.P. lifted its position in shares of U.S. Physical Therapy by 1.0% during the 2nd quarter. Pinebridge Investments L.P. now owns 1,650 shares of the company’s stock worth $100,000 after buying an additional 17 shares in the last quarter. State of Alaska Department of Revenue lifted its position in shares of U.S. Physical Therapy by 77.8% during the 2nd quarter. State of Alaska Department of Revenue now owns 2,454 shares of the company’s stock worth $148,000 after buying an additional 1,074 shares in the last quarter. Sei Investments Co. lifted its position in shares of U.S. Physical Therapy by 31.8% during the 2nd quarter. Sei Investments Co. now owns 2,576 shares of the company’s stock worth $155,000 after buying an additional 622 shares in the last quarter. Municipal Employees Retirement System of Michigan lifted its position in shares of U.S. Physical Therapy by 3.1% during the 2nd quarter. Municipal Employees Retirement System of Michigan now owns 2,950 shares of the company’s stock worth $178,000 after buying an additional 90 shares in the last quarter. Finally, Oppenheimer Asset Management Inc. bought a new position in shares of U.S. Physical Therapy during the 1st quarter worth approximately $221,000. 94.56% of the stock is currently owned by hedge funds and other institutional investors.

U.S. Physical Therapy Company Profile

U.S. Physical Therapy, Inc, through its subsidiaries, operates outpatient physical therapy clinics that provide pre-and post-operative care, and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers and neurological-related injuries.

Analyst Recommendations for U.S. Physical Therapy (NYSE:USPH)

Receive News & Ratings for U.S. Physical Therapy Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for U.S. Physical Therapy Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.